Beijing Tongrentang Co Ltd
SSE:600085
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CN |
|
Beijing Tongrentang Co Ltd
SSE:600085
|
41.4B CNY |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
256.6B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
233.8B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
222.9B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.7B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.3B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.9B USD |
Loading...
|
Market Distribution
| Min | -2 148% |
| 30th Percentile | 14.3% |
| Median | 23% |
| 70th Percentile | 34.6% |
| Max | 775.2% |
Other Profitability Ratios
Beijing Tongrentang Co Ltd
Glance View
Nestled in the heart of Beijing's bustling historic district, Beijing Tongrentang Co. Ltd. trace their origins back to 1669 during the Qing Dynasty. This venerable institution has often been heralded as the steward of traditional Chinese medicine (TCM), expertly bridging over three centuries of heritage with the demands of modern healthcare. The company's deep-rooted ethos is centered on the enduring principles of TCM, which emphasize balance and holistic well-being, a philosophy that they have meticulously preserved and adapted over generations. The intricate potions, herbal remedies, and elaborate tonics they craft are derived from a unique blend of ancient recipes and rigorous quality standards, ensuring both authenticity and efficacy. This reverence for tradition, coupled with a commitment to innovation, underpin the strength and credibility of Tongrentang's brand, allowing it to not only maintain but also expand its standing globally. From the cobblestones of Beijing, Tongrentang's operations today encompass a sophisticated network of production facilities, retail outlets, and strategic partnerships, turning the company into a formidable player in the health sector. While steeped in history, this hallmark of traditional Chinese medicine makes its earnings through a modern business model that includes pharmaceuticals, healthcare services, and retail. Their production capabilities boast advanced manufacturing technologies that complement their traditional processes, ensuring scalable and efficient operations without compromising the character of their products. Retail remains a core avenue, with a vast array of stores in China and abroad that serve as conduits for both commerce and education, introducing new generations to TCM. Additionally, Tongrentang has successfully ventured into healthcare services, with clinics providing wellness treatments and consultations that encapsulate the essence of their medicinal philosophy, thus diversifying income streams while deepening consumer engagement with its storied brand.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Beijing Tongrentang Co Ltd is 43.2%, which is below its 3-year median of 45%.
Over the last 3 years, Beijing Tongrentang Co Ltd’s Gross Margin has decreased from 46.8% to 43.2%. During this period, it reached a low of 43.2% on Sep 30, 2025 and a high of 48.1% on Dec 31, 2022.